Flen Health

Flen Health is a Belgium-based, family-owned biopharmaceutical and medical device company dedicated to advancing wound care and skin-healing solutions for use in clinical settings worldwide. The company develops and markets innovative, enzyme-based and dermatological products such as Flaminal®, Flamigel®, and related therapies, which are routinely used in hospitals, outpatient clinics, and home-care environments for the management of acute and chronic wounds, radiotherapy-induced skin reactions, pressure ulcers, and superficial skin injuries. It maintains a strong clinical focus by supporting real-world evidence, clinical case reports, professional training programs, and collaborations with healthcare professionals and wound-care specialists, underscoring its commitment to clinically proven, patient-centric solutions and continuous research-driven innovation.